Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Ashok AGARWAL; Neel PAREKH; Manesh-Kumar PANNER-SELVAM; Ralf HENKEL; Rupin SHAH; Sheryl-T HOMA; Ranjith RAMASAMY; Edmund KO; Kelton TREMELLEN; Sandro ESTEVES; Ahmad MAJZOUB; Juan-G ALVAREZ; David-K GARDNER; Channa-N JAYASENA; Jonathan-W RAMSAY; Chak-Lam CHO; Ramadan SALEH; Denny SAKKAS; James-M HOTALING; Scott-D LUNDY; Sarah VIJ; Joel MARMAR; Jaime GOSALVEZ; Edmund SABANEGH; Hyun-Jun PARK; Armand ZINI; Parviz KAVOUSSI; Sava MICIC; Ryan SMITH; Gian-Maria BUSETTO; Mustafa-Emre BAKIRCIOĞLU; Gerhard HAIDL; Giancarlo BALERCIA; Nicolás-Garrido PUCHALT; Moncef BEN-KHALIFA; Nicholas TADROS; Jackson KIRKMAN-BROWNE; Sergey MOSKOVTSEV; Xuefeng HUANG; Edson BORGES; Daniel FRANKEN; Natan BAR-CHAMA; Yoshiharu MORIMOTO; Kazuhisa TOMITA; Vasan-Satya SRINI; Willem OMBELET; Elisabetta BALDI; Monica MURATORI; Yasushi YUMURA; Sandro LA-VIGNERA; Raghavender KOSGI; Marlon-P MARTINEZ; Donald-P EVENSON; Daniel-Suslik ZYLBERSZTEJN; Matheus ROQUE; Marcello COCUZZA; Marcelo VIEIRA; Assaf BEN-MEIR; Raoul ORVIETO; Eliahu LEVITAS; Amir WISER; Mohamed ARAFA; Vineet MALHOTRA; Sijo-Joseph PAREKATTIL; Haitham ELBARDISI; Luiz CARVALHO; Rima DADA; Christophe SIFER; Pankaj TALWAR; Ahmet GUDELOGLU; Ahmed-M-A MAHMOUD; Khaled TERRAS; Chadi YAZBECK; Bojanic NEBOJSA; Damayanthi DURAIRAJANAYAGAM; Ajina MOUNIR; Linda-G KAHN; Saradha BASKARAN; Rishma-Dhillon PAI; Donatella PAOLI; Kristian LEISEGANG; Mohamed-Reza MOEIN; Sonia MALIK; Onder YAMAN; Luna SAMANTA; Fouad BAYANE; Sunil-K JINDAL; Muammer KENDIRCI; Baris ALTAY; Dragoljub PEROVIC; Avi HARLEV.
The World Journal of Men's Health ; : 296-312, 2019.
Article in English | WPRIM | ID: wpr-761886

ABSTRACT

Despite advances in the field of male reproductive health, idiopathic male infertility, in which a man has altered semen characteristics without an identifiable cause and there is no female factor infertility, remains a challenging condition to diagnose and manage. Increasing evidence suggests that oxidative stress (OS) plays an independent role in the etiology of male infertility, with 30% to 80% of infertile men having elevated seminal reactive oxygen species levels. OS can negatively affect fertility via a number of pathways, including interference with capacitation and possible damage to sperm membrane and DNA, which may impair the sperm's potential to fertilize an egg and develop into a healthy embryo. Adequate evaluation of male reproductive potential should therefore include an assessment of sperm OS. We propose the term Male Oxidative Stress Infertility, or MOSI, as a novel descriptor for infertile men with abnormal semen characteristics and OS, including many patients who were previously classified as having idiopathic male infertility. Oxidation-reduction potential (ORP) can be a useful clinical biomarker for the classification of MOSI, as it takes into account the levels of both oxidants and reductants (antioxidants). Current treatment protocols for OS, including the use of antioxidants, are not evidence-based and have the potential for complications and increased healthcare-related expenditures. Utilizing an easy, reproducible, and cost-effective test to measure ORP may provide a more targeted, reliable approach for administering antioxidant therapy while minimizing the risk of antioxidant overdose. With the increasing awareness and understanding of MOSI as a distinct male infertility diagnosis, future research endeavors can facilitate the development of evidence-based treatments that target its underlying cause.


Subject(s)
Female , Humans , Male , Antioxidants , Classification , Clinical Protocols , Diagnosis , DNA , Embryonic Structures , Fertility , Health Expenditures , Infertility , Infertility, Male , Membranes , Ovum , Oxidants , Oxidation-Reduction , Oxidative Stress , Reactive Oxygen Species , Reducing Agents , Reproductive Health , Semen , Spermatozoa , Subject Headings
2.
Asian Journal of Andrology ; (6): 1-8, 2018.
Article in Chinese | WPRIM | ID: wpr-842676

ABSTRACT

Spermatozoa retrieved from the testis of men with high levels of sperm DNA fragmentation (SDF) in the neat semen tend to have better DNA quality. Given the negative impact of SDF on the outcomes of Assisted Reproductive Technology (ART), an increased interest has emerged about the use of testicular sperm for intracytoplasmic sperm injection (Testi-ICSI). In this article, we used a SWOT (strengths, weaknesses, opportunities, and threats) analysis to summarize the advantages and drawbacks of this intervention. The rationale of Testi-ICSI is bypass posttesticular DNA fragmentation caused by oxidative stress during sperm transit through the epididymis. Hence, oocyte fertilization by genomically intact testicular spermatozoa may be optimized, thus increasing the chances of creating a normal embryonic genome and the likelihood of achieving a live birth, as recently demonstrated in men with high SDF. However, there is still limited evidence as regards the clinical efficacy of Testi-ICSI, thus creating opportunities for further confirmatory clinical research as well as investigation of Testi-ICSI in clinical scenarios other than high SDF. Furthermore, Testi-ICSI can be compared to other laboratory preparation methods for deselecting sperm with damaged DNA. At present, the available literature supports the use of testicular sperm when performing ICSI in infertile couples whose male partners have posttesticular SDF. Due to inherent risks of sperm retrieval, Testi-ICSI should be offered when less invasive treatments for alleviating DNA damage have failed. A call for continuous monitoring is nonetheless required concerning the health of generated offspring and the potential complications of sperm retrieval.

3.
Asian Journal of Andrology ; (6): 596-599, 2016.
Article in Chinese | WPRIM | ID: wpr-842863

ABSTRACT

A recently published article described how a fertility center in the United States implemented air quality control to newly designed in vitro fertilization (IVF) laboratory. A highly-efficient air filtration was achieved by installing a centered system supplying filtered air to the IVF laboratory and related critical areas, combining air particulate and volatile organic compound (VOC) filtration. As a consequence, live birth rates were increased by improvements in air quality. This article highlights the key aspects of air contamination in the IVF context. The topic is important not only to IVF specialists but also to Andrologists due to the great number of male infertility patients referred to assisted reproductive technology (ART) treatments. The evidence is growing that laboratory air quality is paramount importance for improved IVF outcome.

SELECTION OF CITATIONS
SEARCH DETAIL